Clinical and prognostic features of adult patients with gangliogliomas

Neuro-Oncology

Volumn 16, Issue 3, 2014, Pages 409-413

  Yust Katz, Shlomit ^a   Anderson, Mark Daniel ^b   Liu, Diane ^a   Wu, Jimin ^a   Yuan, Ying ^a   Olar, Adriana ^a   Fuller, Greg N ^a   Brown, Paul D ^a   De Groot, John F ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF MISSISSIPPI   (United States)

Author keywords

adults; ganglioglioma; malignant transformation; progression; treatment

Indexed keywords

ADULTS; GANGLIOGLIOMA; MALIGNANT TRANSFORMATION; PROGRESSION; TREATMENT;

ADOLESCENT; ADULT; BRAIN NEOPLASMS; FEMALE; GANGLIOGLIOMA; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; PROGNOSIS; YOUNG ADULT;

EID: 84894226867     PISSN: 15228517     EISSN: 15235866     Source Type: Journal    
DOI: 10.1093/neuonc/not169     Document Type: Article

References (14)

1. Becker A, Wiestler OD, Figarella-Branger D, Blumcke I. Ganglioglioma and Gangliocytoma. 4th edn. Lyon: International Agency for Research on Cancer; 2007.
2. Zentner J, Hufnagel A,Wolf HK, et al. Surgical treatment of neoplasms associated with medically intractable epilepsy. Neurosurgery. 1997; 41(2):378-386.
3. Luyken C, Blumcke I, Fimmers R, Urbach H, Wiestler OD, Schramm J. Supratentorial gangliogliomas: histopathologic grading and tumor recurrence in 184 patients with a median follow-up of 8 years. Cancer. 2004;101(1):146-155.
4. Compton JJ, Laack NN, Eckel LJ, Schomas DA, Giannini C, Meyer FB. Long-term outcomes for low-grade intracranial ganglioglioma: 30-year experience from the Mayo Clinic. J Neurosurg. 2012;117(5): 825-830.
5. Southwell DG, Garcia PA, Berger MS, Barbaro NM, Chang EF. Long-term seizure control outcomes after resection of gangliogliomas. Neurosurgery. 2012;70(6):1406-1413; discussion 1413-1414.
6. Rades D, Zwick L, Leppert J, et al. The role of postoperative radiotherapy for the treatment of gangliogliomas. Cancer. 2010;116(2):432-442.
7. Mehta MP. Neuro-oncology: gangliogliomas-what is the appropriate management strategy? Nat Rev Neurol. 2010;6(4):190-191.
8. Rumana CS, Valadka AB. Radiation therapy and malignant degeneration of benign supratentorial gangliogliomas. Neurosurgery. 1998;42(5):1038-1043.
9. Selvanathan SK, Hammouche S, Salminen HJ, Jenkinson MD. Outcome and prognostic features in anaplastic ganglioglioma: analysis of cases from the SEER database. J Neurooncol. 2011;105(3):539-545.
10. Engel J,Van Ness P, Rasmussen T, Ojemann L. OutcomeWith Respect to Epileptic Seizures. 2nd edn. New York: Raven; 1993.
11. Wieser HG, Blume WT, Fish D, et al. ILAE commission report. Proposal for a new classification of outcome with respect to epileptic seizures following epilepsy surgery. Epilepsia. 2001;42(2):282-286.
12. Rumana CS, Valadka AB, Contant CF. Prognostic factors in supratentorial ganglioglioma. Acta Neurochir (Wien). 1999;141(1): 63-68; discussion 68-69.
13. DeMarchi R, Abu-Abed S, Munoz D, Loch Macdonald R. Malignant ganglioglioma: case report and review of literature. J Neurooncol. 2011;101(2):311-318.
14. Krouwer HG, Davis RL, McDermott MW, Hoshino T, Prados MD. Gangliogliomas: a clinicopathological study of 25 cases and review of the literature. J Neurooncol. 1993;17(2):139-154.